论文部分内容阅读
目的：探讨对脑梗死患者运用舒血宁注射液治疗的临床有效性与安全性。方法：2013年6月-2014年6月收治脑梗死患者128例，随机分成两组，每组64例。对照组接受常规基础治疗，观察组在此基础上接受舒血宁注射液治疗，分析并评估两组的临床治疗结果。结果：治疗后观察组临床总疗效95.3%，与对照组71.8%相比，差异有统计学意义(P＜0.05)。观察组治疗后的Barthel指数评分较治疗前、对照组改善更明显(P＜0.05)。两组治疗期间均无严重不良反应出现。结论：舒血宁注射液治疗脑梗死对缓解临床症状、促使神经功能尽早恢复有确切效果，适合在今后的临床上普及应用。“,”Objective:To explore the clin ical effect and safety of Shuxuening injection in the treatment of patients with cerebral infarction.Methods:128 patients with cerebral infarction from June 2013 to June 2014 were randomLy divided into two groups,64 cases in each group.The control group were treated with regular treatment,and the observation group were treated with Shuxuening Injection based on regular treatment.Analyze the clinical treatment results of the two groups.Results:After treatment,the total clinical effectiveness of the observation group 95.3% ;compared with that of the control group 71.8% ,the difference was statistically significant(P<0.05).Barthel index score of the observation group after treatment improved more significantly than before treatment or that of the control group,and the differences were statistically significant(P<0.05).There were no serious adverse reaction in the two groups during the treatment.Conclusion:Shuxuening Injection has the exact effects of relieving the clinical symptoms and promoting neural function recovery sooner in the treatment of cerebral infarction,which is suitable for popularization and application in the future.